[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Sleep Aids Market 2021

May 2021 | 32 pages | ID: G2435C7CEA26EN
StrategyHelix Inc

US$ 2,750.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The global sleep aids market in terms of revenue is set to grow by US$ 34 billion during 2021-2027, growing at a compound annual growth rate (CAGR) of 6.6% during the forecast period, according to data and analytics company StrategyHelix. Growth in the geriatric and obese population, increasing prevalence of sleep disorders, rise in disposable income are the key factors driving market growth.

The report provides up-to-date market size data for period 2017-2020 and forecast to 2027 covering key market aspects like sales value for sleep aids. The global sleep aids market is segmented on the basis of product, sleep disorder, region. By product, it is categorized into mattress & pillows, sleep laboratories, medications, sleep apnea devices, and others. The mattress & pillows segment held the largest market share in 2020. By sleep disorder, the sleep aids market is divided into insomnia, sleep apnea, restless leg syndrome, narcolepsy, sleep walking, and others. Based on region, the sleep aids market is divided into North America, Asia Pacific, Europe, and Rest of the World (ROW).

The report has profiled some of the key players of the market such as Apnea Sciences Corporation, Boehringer Ingelheim International GmbH, Cadwell Laboratories Inc., Fisher & Paykel Healthcare Corporation Limited, Natus Medical Incorporated, Nihon Kohden Corporation, Pfizer Inc, ResMed Inc., Sanofi S.A..

The report is an invaluable resource for companies and organizations active in this industry. It provides a cohesive picture of the sleep aids market to help drive informed decision making for industry executives, policy makers, academic, and analysts.

Report Scope
Product: mattress & pillows, sleep laboratories, medications, sleep apnea devices, and others
Sleep disorder: insomnia, sleep apnea, restless leg syndrome, narcolepsy, sleep walking, and others
Region: North America, Asia Pacific, Europe, and Rest of the World (ROW)
Years Considered: this report covers the period 2017 to 2027

Key Benefits for Stakeholders
Get a comprehensive picture of the global sleep aids market
Pinpoint growth sectors and trends for investment
Understand what the future of the global sleep aids market looks like
Identify the competitive landscape and window of opportunity
1. MARKET DEFINITION

2. RESEARCH METHODOLOGY

3. MARKET DATA & OUTLOOK

3.1 Market Value
3.2 Market Value Forecast

4. SLEEP AIDS MARKET BY PRODUCT

4.1 Mattress & Pillows
4.2 Sleep Laboratories
4.3 Medications
4.4 Sleep Apnea Devices
4.5 Others

5. SLEEP AIDS MARKET BY SLEEP DISORDER

5.1 Insomnia
5.2 Sleep Apnea
5.3 Restless Leg Syndrome
5.4 Narcolepsy
5.5 Sleep Walking
5.6 Others

6. SLEEP AIDS MARKET BY REGION

6.1 North America
6.2 Asia Pacific
6.3 Europe
6.4 Rest Of The World (Row)

7. COMPANY PROFILES

7.1 Apnea Sciences Corporation
7.2 Boehringer Ingelheim International GmbH
7.3 Cadwell Laboratories, Inc.
7.4 Fisher & Paykel Healthcare Corporation Limited
7.5 Natus Medical Incorporated
7.6 Nihon Kohden Corporation
7.7 Pfizer, Inc
7.8 ResMed Inc.
7.9 Sanofi S.A.

8. APPENDIX

8.1 About StrategyHelix
8.2 Disclaimer


More Publications